GI & Endoscopy

Motus GI enrolled the first patient into its reliable endoscopic diagnosis utilizing cleansing enhancement or REDUCE study that'll test the ability of the Pure-Vu System to properly prepare bowels for a diagnostic colonoscopy procedure.

A study, published in JAMA, examined the effects of follow-up surveillance on patients undergoing curative surgery for colorectal cancer.

Here are three updates on GI companies from the past week.

A study, published in Gut, examined endoscopy and osophagogastroduodenoscopies infection rates in the ASC setting.

The American Cancer Society, CDC, National Cancer Institute and North American Association of Central Cancer Registries provided an update on cancer occurrence and trends in the U.S., published in Wiley Online Library, finding mortality rates for 14 of the 20…

Prescient Surgical's novel wound retractor CleanCision is associated with reduced bacterial contamination in colorectal surgery, according to a study in the World Journal of Surgery.

Maria Chang, MD, is a gastroenterologist at Oklahoma City-based Digestive Disease Specialists.

A potentially life expectancy-increasing DNA-based colorectal cancer vaccine treatment is set to undergo its first human trial, according to research to be presented at Digestive Disease Week 2018, June 2 to June 5 in Washington, D.C.

A new blue dye tablet can improve polyp detection during a colonoscopy by approximately 9 percent, according to research to be presented at Digestive Disease Week 2018, June 2 to June 5 in Washington, D.C.

Around 44 percent of gastroenterologists report receiving fee-for-service reimbursement, meaning more than half participate in value-based care contracts, according to the Medscape Gastroenterologist Compensation Report 2018.